Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Noteable

<< Previous

Bullboard Posts

Next >>

Comment by digital130on Feb 24, 2024 9:53pm

150 Views

Post# 35897588

RE:Noteable

I dont think bots read his posts. Im sure there are a few of them who search technicals of trading and found oncy. Programmed to find weakness. They end up helping out on the way up and on the way down. Its all about making money and with 75 percent of the trading or more done by bots price to them doesnt matter.

Seen this movie before.

Take care

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?